La maladie de Parkinson en France (serveur d'exploration) - Checkpoint (Ncbi)

Index « ISSN » - entrée « 0014-3022 »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
0014-2999 < 0014-3022 < 0014-4819  Facettes :

List of bibliographic references

Number of relevant bibliographic references: 11.
Ident.Authors (with country if any)Title
000073 (1999) M. Gentil [France] ; C L Tournier ; P. Pollak ; A L BenabidEffect of bilateral subthalamic nucleus stimulation and dopatherapy on oral control in Parkinson's disease.
000145 (2000) M. Gentil [France] ; P. Garcia-Ruiz ; P. Pollak ; A L BenabidEffect of bilateral deep-brain stimulation on oral control of patients with parkinsonism.
000174 (2001) F. Durif [France] ; I. Devaux ; J J Pere ; J C Delumeau ; I. BourdeixEfficacy and tolerability of entacapone as adjunctive therapy to levodopa in patients with Parkinson's disease and end-of-dose deterioration in daily medical practice: an open, multicenter study.
000267 (2002) Nathalie Gérard [France] ; Stéphane Panserat ; Gérard LucotteRoles of gender, age at onset and environmental risk in the frequency of CYP2D6-deficient alleles in patients with Parkinson's disease.
000295 (2003) S. Thobois [France] ; S. Corvaisier ; P. Mertens ; C. Di Guardo ; H. Mollion ; M. Guenot ; F. Rochefort ; G. Chazot ; M. Sindou ; E. BroussolleThe timing of antiparkinsonian treatment reduction after subthalamic nucleus stimulation.
000491 (1992) F. Durif [France] ; P. Pollak ; M. Hommel ; C. Ardouin ; J F Le Bas ; G. Crouzet ; J. PerretRelationship between levodopa-independent symptoms and central atrophy evaluated by magnetic resonance imaging in Parkinson's disease.
001C38 (1987) P. Rondot [France] ; M. Ziegler ; N. Aymard ; J. HolzerClinical trial of Madopar HBS in parkinsonian patients with fluctuating drug response after long-term levodopa therapy.
001D54 (1993) E C Hirsch [France]Does oxidative stress participate in nerve cell death in Parkinson's disease?
001E40 (1996) P. Pollak [France] ; A L Benabid ; P. Limousin ; P. KrackTreatment of Parkinson's disease. New surgical treatment strategies.
001E49 (1997) P. Limousin [France] ; B. Memin ; P. PollakTreatment of dystonia occurring in parkinsonian syndromes by botulinum toxin.
001F46 (1998) J. De Sèze [France] ; L. Defebvre ; M M Ruchoux ; S. Blond ; J. De Reuck ; A. DestéeHemiparkinsonism revealing an infiltrating low-grade oligodendroglial tumor.

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/ParkinsonFranceV1/Data/Ncbi/Checkpoint
HfdIndexSelect -h $EXPLOR_AREA/Data/Ncbi/Checkpoint/ISSN.i -k "0014-3022" 
HfdIndexSelect -h $EXPLOR_AREA/Data/Ncbi/Checkpoint/ISSN.i  \
                -Sk "0014-3022" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Ncbi/Checkpoint/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Sante
   |area=    ParkinsonFranceV1
   |flux=    Ncbi
   |étape=   Checkpoint
   |type=    indexItem
   |index=    ISSN.i
   |clé=    0014-3022
}}

Wicri

This area was generated with Dilib version V0.6.29.
Data generation: Wed May 17 19:46:39 2017. Site generation: Mon Mar 4 15:48:15 2024